Cargando…

Oral administration of thiol-reducing agents mitigates gut barrier disintegrity and bacterial lipopolysaccharide translocation in a rat model of biliary obstruction

It has been well documented that cirrhosis is associated with the intestinal injury. Intestinal injury in cirrhosis could lead to bacterial lipopolysaccharide (LPS) translocation to the systemic circulation. It has been found that high plasma LPS is connected with higher morbidity and mortality in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ommati, Mohammad Mehdi, Farshad, Omid, Niknahad, Hossein, Mousavi, Khadijeh, Moein, Marjan, Azarpira, Negar, Mohammadi, Hamidreza, Jamshidzadeh, Akram, Heidari, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663936/
https://www.ncbi.nlm.nih.gov/pubmed/34909638
http://dx.doi.org/10.1016/j.crphar.2020.06.001
_version_ 1784613752012800000
author Ommati, Mohammad Mehdi
Farshad, Omid
Niknahad, Hossein
Mousavi, Khadijeh
Moein, Marjan
Azarpira, Negar
Mohammadi, Hamidreza
Jamshidzadeh, Akram
Heidari, Reza
author_facet Ommati, Mohammad Mehdi
Farshad, Omid
Niknahad, Hossein
Mousavi, Khadijeh
Moein, Marjan
Azarpira, Negar
Mohammadi, Hamidreza
Jamshidzadeh, Akram
Heidari, Reza
author_sort Ommati, Mohammad Mehdi
collection PubMed
description It has been well documented that cirrhosis is associated with the intestinal injury. Intestinal injury in cirrhosis could lead to bacterial lipopolysaccharide (LPS) translocation to the systemic circulation. It has been found that high plasma LPS is connected with higher morbidity and mortality in cirrhotic patients. Therefore, finding therapeutic approaches to mitigate this complication has great clinical value. Several investigations mentioned the pivotal role of oxidative stress in cirrhosis-associated intestinal injury. It has been well-known that the redox balance of enterocytes is disturbed in cirrhotic patients. In the current study, the effects of thiol-reducing agents N-acetylcysteine (NAC) (0.5 and 1% w: v) and dithiothreitol (DTT) (0.5 and 1% w: v) on biomarkers of oxidative stress, tissue histopathological alterations, and LPS translocation is investigated in a rat model of cirrhosis. Bile duct ligation (BDL) surgery was used to induce cirrhosis in male Sprague-Dawley rats. Animals (n ​= ​48; 8 animals/group) were supplemented with NAC and DTT for 28 consecutive days. Significant changes in ileum and colon markers of oxidative stress were evident in BDL rats as judged by increased reactive oxygen species (ROS), lipid peroxidation, oxidized glutathione (GSSG), and protein carbonylation along with decreased antioxidant capacity and glutathione (GSH) content. Blunted villus, decreased villus number, and inflammation was also detected in the intestine of BDL animals. Moreover, serum LPS level was also significantly higher in BDL rats. NAC and DTT administration (0.5 and 1% w: v, gavage) significantly decreased biomarkers of oxidative stress, mitigated intestinal histopathological alterations, and restored tissue antioxidant capacity. Moreover, NAC and/or DTT significantly suppressed LPS translocation to the systemic circulation. The protective effects of thiol reducing agents in the intestine of cirrhotic rats could be attributed to the effect of these chemicals on the cellular redox environment and biomarkers of oxidative stress.
format Online
Article
Text
id pubmed-8663936
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-86639362021-12-13 Oral administration of thiol-reducing agents mitigates gut barrier disintegrity and bacterial lipopolysaccharide translocation in a rat model of biliary obstruction Ommati, Mohammad Mehdi Farshad, Omid Niknahad, Hossein Mousavi, Khadijeh Moein, Marjan Azarpira, Negar Mohammadi, Hamidreza Jamshidzadeh, Akram Heidari, Reza Curr Res Pharmacol Drug Discov Article It has been well documented that cirrhosis is associated with the intestinal injury. Intestinal injury in cirrhosis could lead to bacterial lipopolysaccharide (LPS) translocation to the systemic circulation. It has been found that high plasma LPS is connected with higher morbidity and mortality in cirrhotic patients. Therefore, finding therapeutic approaches to mitigate this complication has great clinical value. Several investigations mentioned the pivotal role of oxidative stress in cirrhosis-associated intestinal injury. It has been well-known that the redox balance of enterocytes is disturbed in cirrhotic patients. In the current study, the effects of thiol-reducing agents N-acetylcysteine (NAC) (0.5 and 1% w: v) and dithiothreitol (DTT) (0.5 and 1% w: v) on biomarkers of oxidative stress, tissue histopathological alterations, and LPS translocation is investigated in a rat model of cirrhosis. Bile duct ligation (BDL) surgery was used to induce cirrhosis in male Sprague-Dawley rats. Animals (n ​= ​48; 8 animals/group) were supplemented with NAC and DTT for 28 consecutive days. Significant changes in ileum and colon markers of oxidative stress were evident in BDL rats as judged by increased reactive oxygen species (ROS), lipid peroxidation, oxidized glutathione (GSSG), and protein carbonylation along with decreased antioxidant capacity and glutathione (GSH) content. Blunted villus, decreased villus number, and inflammation was also detected in the intestine of BDL animals. Moreover, serum LPS level was also significantly higher in BDL rats. NAC and DTT administration (0.5 and 1% w: v, gavage) significantly decreased biomarkers of oxidative stress, mitigated intestinal histopathological alterations, and restored tissue antioxidant capacity. Moreover, NAC and/or DTT significantly suppressed LPS translocation to the systemic circulation. The protective effects of thiol reducing agents in the intestine of cirrhotic rats could be attributed to the effect of these chemicals on the cellular redox environment and biomarkers of oxidative stress. Elsevier 2020-06-16 /pmc/articles/PMC8663936/ /pubmed/34909638 http://dx.doi.org/10.1016/j.crphar.2020.06.001 Text en © 2020 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Ommati, Mohammad Mehdi
Farshad, Omid
Niknahad, Hossein
Mousavi, Khadijeh
Moein, Marjan
Azarpira, Negar
Mohammadi, Hamidreza
Jamshidzadeh, Akram
Heidari, Reza
Oral administration of thiol-reducing agents mitigates gut barrier disintegrity and bacterial lipopolysaccharide translocation in a rat model of biliary obstruction
title Oral administration of thiol-reducing agents mitigates gut barrier disintegrity and bacterial lipopolysaccharide translocation in a rat model of biliary obstruction
title_full Oral administration of thiol-reducing agents mitigates gut barrier disintegrity and bacterial lipopolysaccharide translocation in a rat model of biliary obstruction
title_fullStr Oral administration of thiol-reducing agents mitigates gut barrier disintegrity and bacterial lipopolysaccharide translocation in a rat model of biliary obstruction
title_full_unstemmed Oral administration of thiol-reducing agents mitigates gut barrier disintegrity and bacterial lipopolysaccharide translocation in a rat model of biliary obstruction
title_short Oral administration of thiol-reducing agents mitigates gut barrier disintegrity and bacterial lipopolysaccharide translocation in a rat model of biliary obstruction
title_sort oral administration of thiol-reducing agents mitigates gut barrier disintegrity and bacterial lipopolysaccharide translocation in a rat model of biliary obstruction
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663936/
https://www.ncbi.nlm.nih.gov/pubmed/34909638
http://dx.doi.org/10.1016/j.crphar.2020.06.001
work_keys_str_mv AT ommatimohammadmehdi oraladministrationofthiolreducingagentsmitigatesgutbarrierdisintegrityandbacteriallipopolysaccharidetranslocationinaratmodelofbiliaryobstruction
AT farshadomid oraladministrationofthiolreducingagentsmitigatesgutbarrierdisintegrityandbacteriallipopolysaccharidetranslocationinaratmodelofbiliaryobstruction
AT niknahadhossein oraladministrationofthiolreducingagentsmitigatesgutbarrierdisintegrityandbacteriallipopolysaccharidetranslocationinaratmodelofbiliaryobstruction
AT mousavikhadijeh oraladministrationofthiolreducingagentsmitigatesgutbarrierdisintegrityandbacteriallipopolysaccharidetranslocationinaratmodelofbiliaryobstruction
AT moeinmarjan oraladministrationofthiolreducingagentsmitigatesgutbarrierdisintegrityandbacteriallipopolysaccharidetranslocationinaratmodelofbiliaryobstruction
AT azarpiranegar oraladministrationofthiolreducingagentsmitigatesgutbarrierdisintegrityandbacteriallipopolysaccharidetranslocationinaratmodelofbiliaryobstruction
AT mohammadihamidreza oraladministrationofthiolreducingagentsmitigatesgutbarrierdisintegrityandbacteriallipopolysaccharidetranslocationinaratmodelofbiliaryobstruction
AT jamshidzadehakram oraladministrationofthiolreducingagentsmitigatesgutbarrierdisintegrityandbacteriallipopolysaccharidetranslocationinaratmodelofbiliaryobstruction
AT heidarireza oraladministrationofthiolreducingagentsmitigatesgutbarrierdisintegrityandbacteriallipopolysaccharidetranslocationinaratmodelofbiliaryobstruction